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Abstract
Background: Methods for the integrative analysis of multi-omics data are required to draw a more complete and
accurate picture of the dynamics of molecular systems. The complexity of biological systems, the technological limits,
the large number of biological variables and the relatively low number of biological samples make the analysis of
multi-omics datasets a non-trivial problem.
Results and Conclusions: We review the most advanced strategies for integrating multi-omics datasets, focusing on
mathematical and methodological aspects.
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Background
Biological functions are exploited by systems of inter-
acting molecules and macromolecules that take part in
physical and biochemical processes in structured environ-
ments. Different types of high-throughput technologies
allow us to collect information on the molecular com-
ponents of biological systems. Each of such technolo-
gies (e.g. nucleotide sequencing, DNA-chips and protein
mass spectrometry) is designed to simultaneously col-
lect a large set of molecular data of a specific kind: e.g.
nucleotide sequences, gene expression and protein abun-
dances. Therefore, in order to draw amore comprehensive
view of biological processes, experimental data made on
different layers have to be integrated and analyzed. The
complexity of biological systems, the technological limits,
the large number of biological variables and the rela-
tively low number of biological samples make integrative
analyses a challenging issue. Hence, the development of
methods for the integrative analysis of multi-layer datasets
is one of the most relevant problems computational scien-
tists are addressing nowadays.
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A few reviews exist on this topic. For example, Berger
et al. [1] described integrative approaches in one of
the sections of their work, which is also focused on
tools for the analysis of single omics layers, while
Kristensen et al. [2] presented objectives, methods and
computational tools of integrative genomics, with a
particular focus on the applications related to cancer
research. Conversely, we would like to focus on mathe-
matical aspects and illustrate the solutions found to the
problem of multi-omics data integration.
The classification of the approaches presented in the lit-
erature as multi-omics methods is a non-trivial task for
at least three reasons. First, most of the computational
approaches developed so far are pipelines of analysis that
apply several methods to carry out a sequence of tasks;
therefore, different pipelines share some methods: for
example, partial least squares regression is included in
both Integromics [3] and sMBPLS [4]. Second, pipelines
presented for addressing a particular problem can be also
used, with minor modifications, to solve another problem,
possibly with other types of omics. Third, several tools can
be used in a supervised or unsupervised setting, according
to the formulation of the problem.
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Methods
On the basis of methodological aspects, we will con-
sider two main criteria. The first is whether the approach
uses graphs to model the interactions among variables.
These approaches, designated as “network-based” (NB),
take into account currently known (e.g. protein-protein
interactions) or predicted (e.g. from correlation analy-
sis) relationships between biological variables. In this
class, graphmeasures (e.g. degree, connectivity, centrality)
and graph algorithms (e.g. sub-network identification) are
used to identify valuable biological information. Impor-
tantly, networks are used in the modeling of the cell’s
intricate wiring diagram and suggest possible mecha-
nisms of action at the basis of healthy and pathological
phenotypes [5].
The second criterion is whether the approach is
bayesian (BY) [6], that is, it uses a statistical model in
which, starting from an a priori reasonable assumption
about the data probability distribution, parametric or non-
parametric, it is possible to compute the updated poste-
rior probability distribution making use of the Bayes’ rule;
of course the posterior distribution depends on dataset
measurements [7]. In the network-based area, bayesian
networks [8–10] are another promising framework for the
analysis multi-omics data.
Therefore, we will arrange integrative methods in four
classes: network-free non-bayesian (NF-NBY), network-
free bayesian (NF-BY), network-based non-bayesian (NB-
NBY) and network-based bayesian (NB-BY) methods. We
will give an overview of the methods that have been pro-
posed for the analysis of at least two different types of
omics datasets and describe with more details the spe-
cific mathematical grounds. In particular, we choose to
consider in detail the mathematical aspects of the most




Mathematically, the general problem of analyzing multi-
ple omics datasets can be formulated as the sequential or
joint analysis of multiple component-by-sample matrices,
possibly using other data that carry prior information on
components and samples.
The objectives of integrative analysis can be summa-
rized into the following [2] (Fig. 1): (i) the discovery of
Fig. 1 Overview of multi-omics methods. Methods are placed in boxes according to whether they make use of networks and bayesian theory; the
types of omics that each method takes in input (or has been applied to in a case study) is indicated between parentheses. Grey: network-free,
non-bayesian methods; yellow: network-free, bayesian methods; blue: network-based, non-bayesian methods; green: network-based bayesian
methods. Abbreviations: GEN = genome, CC = ChIP-chip, CN = copy number variations, DM = DNA methylation, DS = DNA sequence, Hi-C =
genome-wide data of chromosomal interactions, LOH = loss of heterozigosity, GT = genotype, GE = gene expression, PE = protein expression
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molecular mechanisms; (ii) the clustering of samples (e.g.
individuals); (iii) the prediction of an outcome, such as
survival or efficacy of therapy. Most of the methods are
developed for the first and second objectives, while less
methods carry out prediction.
Integrative approaches can be more or less stringent on
the types of omics considered in input: some methods are
designed to analyze a specific combination of datasets,
while others are more general. For example, Conexic [11]
is tailored for DNA copy number variations (CNV) and
gene expression data, while iCluster [12] can be in prin-
ciple used for the analysis of any combination of omics
encoded as quantitative values on the same set of samples
(Table 1).
As already mentioned, a distinction can be done
between sequential and simultaneous analysis of multiple
layers. In the former case, the results of the analysis of one
layer are refined by means of the subsequent analyses of
further layers. This is the case, for example, of methods
that are designed assuming a causal effect of an omics (e.g.
genomics) on another (e.g. transcriptomics), like MCD
[13] and iPAC [14]. The joint analysis of multiple omics
can be carried out by means of models that consider
each layer as a separate entity: two examples are multi-
variate regression [15] and multi-objective optimization
[16]. Simultaneous analysis may require a preliminary
step of data fusion, which usually involves objects derived
from single-layer analysis: two examples are the fusion of
sample-sample similarity matrices [17] and of gene-gene
kernels matrices [18] calculated on different omics.
Network-free non-bayesian (NF-NBY)
Among the approaches that have been developed for
specific types of omics there are iPAC [14], MCD [13],
CNAmet [19], sMB-PLS [4] and Camelot [15]. iPAC [14]
is an unsupervised approach for the sequential analy-
sis of CNV and gene expression data on the basis of a
series of gene selection criteria: aberrant genes identified
by the analysis of CNV are further studied by corre-
lation analysis of gene expression in order to find the
subset of aberrant genes potentially leading to a substan-
tial shift in transcriptional programs. MCD [13] (Multiple
Table 1 Methods for the analysis of multi-omics datasets
Method Specificity Multi-omics approach Implementation
Camelot [15] Specific Bivariate predictive regression model NA
CNAmet [19] Specific Multi-omics gene-wise scores R
FALDA [21] General FA + LDA of a joint matrix NA
Integromics [3] General Regularized CCA, sparse PLS R
iPAC [14] Specific Sequential NA
MCD [13] Specific Sequential NA
MCIA [20] General Multiple co-inertia analysis R
sMBPLS [4] General Sparse Multi-Block PLS regression Matlab
Coalesce [30] Specific Multi-omics probabilities C++
iCluster [12] General Joint Gaussian latent variable models R
MDI [28] General DMA mixture models Matlab
PSDF [29] General Hierarchical DMA mixture models Matlab
TMD [27] General Hierarchical DMA mixture models Matlab
Kernel Fusion [18] General Integration of omics-specific kernels Matlab
Endeavour [37] General Integration of omics-specific ranks with order statistics Webserver
MOO [16] General Sub-network extraction on MWG R
Multiplex [38] General Joint analysis of multi-layered networks NA
NuChart [35] Specific Analysis of a MWG R
SNF [17] General Similarity network fusion Matlab, R
SteinerNet [33] Specific Sub-network extraction on MWG Webserver
stSVM [34] Specific MWG R
Paradigm [51] General Multi-omics bayesian factor graphs C++
Conexic [11] Specific Sequential Java
Specificity indicates whether the method was designed for a specific combination of omics (specific) or not (general). Legend: MWG = multi-weighted graph; FA = factor
analysis; LDA = linear discriminant analysis; CCA = canonical correlation analysis; PLS = partial least squares; DMA = Dirichelet multinomial allocation; NA = not available
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Concerted Disruption) is another sequential approach.
CNVs, loss of heterozygosity (LOH) and DNA methyla-
tions are analyzed sequentially in order to find changes in
gene copy number accompanied by allelic imbalances and
variations in DNA methylation resulting in gene expres-
sion differences. CNAmet [19] uses gene-wise weights
calculated considering the gene expression in classes of
samples with different CNVs or DNAmethylation pattern;
weights for CNV and DNA methylation are then linearly
combined to define gene-wise statistics, whose signifi-
cance is assessed by permutation analysis. In 2012 Li et
al. presented the sparse Multi-Block Partial Least Squares
(sMB-PLS) regression method [4] for the identification
of regulatory modules from multiple omics. Common
weights are found in order to maximize the covariance
between summary vectors of the input matrices (CNV,
DNA methylation and miRNA expression) and the sum-
mary vector of the output matrix (mRNA expression).
A multi-dimensional regulatory module contains sets of
regulatory factors from different layers that are likely to
jointly contribute to a “gene expression factory”. Camelot
[15] finds the optimal regression model for phenotype
prediction (drug response) on the basis of matched geno-
type and gene expression data. This method suggests the
molecular mechanisms that predict the phenotype under
analysis.
Conversely from the methods above, Integromics [3],
MCIA [20] and the approach of Liu et al. [21] are based on
models of data integration that can be easily applied to dif-
ferent types of omics. Integromics [3] performs integrative
analysis of two types of omics with the main objective of
finding similarities among samples and correlation among
molecular components. It uses a regularized version of
canonical correlation analysis to highlight correlations
between the two datasets and a sparse version of par-
tial least squares regression that includes simultaneous
variable selection in both datasets. In principle, it can
be applied to any pairs of omics that can be encoded as
continuous sample-by-componentsmatrices.Multiple co-
inertia analysis MCIA [20] is an exploratory data analysis
method that identifies co-relationships between multiple
high-dimensional datasets. Based on a covariance opti-
mization criterion, MCIA simultaneously projects several
datasets into the same dimensional space, transform-
ing diverse sets of features onto the same scale. This
analysis leads to the identification of biological mark-
ers and clusters of samples. Liu et al. [21] presented
a method (shortly FALDA) based on standardization
and merger of several omics (namely mRNA, miRNA
and protein data) into a joint (standardized) molecule-
by-sample matrix. Then, factor analysis (FA) and linear
discriminant analysis (LDA) are used to highlight molec-
ular mechanisms that discriminate different classes of
samples.
Many variations of PLS, a common dimensionality
reduction method, have been introduced for the integra-
tion of complex datasets: for example, Integromics [3]
relies on a sparse version of PLS (sPLS), and other vari-
ants of PLS, such as Orthogonal PLS [22], Kernel PLS
[23] or O2-PLS [24], have been described in the lit-
erature. The idea of weighting the behavior of a gene
at different levels and then combining such weights in
order to get an integrated picture, applied so far for gene
expression, CNV and methylation data [19], is a versa-
tile approach that can be applicable to other types of
datasets (e.g. gene expression, somatic mutations and pro-
tein expression). Thus, below we will describe in more
detail Partial Least Squares (PLS) and the use of signal-
to-noise statistics for the integrative analysis of multiple
datasets [19].
Partial least squares
PLS and PCA (Principal Component Analysis) are tech-
niques that seek to identify a small set of features that
work as predictors of the response dataset. While PCA
works in a purely unsupervised fashion, PLS makes use of
the response in order to find appropriate linear combina-
tions of the predictors that define a new set of features. In
PLS the coefficients of the linear combination are chosen
so that the highest weight is assigned to variables that are
most strongly correlated to the response. In this sense we
can say that PLS is a supervised alternative to PCA, for
details see [25].
Multi-block PLS [4] is a method for performing PLS on
a multi-layered dataset. Like any supervised PLS regres-
sion problem, sMBPLS’s set up consists of n (e.g. n = 3)
input layers X1,X2,X3 and a response dataset Y , where
observations are made on the same set of samples. The
goal is to identify MDRMs (Multi dimensional regulatory
modules) that are column subsets of the input datasets
on the same samples that are strongly associated to the
response. First each layer is represented as the first PLS
predictor for i = 1, 2, 3, (Zi = Xi · wi) and the response
Y is treated the same way (U = Y · v), where wi, v are the
loadings and Zi and U are the summary vectors or latent
variables of respectively the input and response datasets.
Then sMBPLS defines Z = b1Z1 + b2Z2 + b3Z3 that is
a summary vector of the three datasets. The weights bi
are supposed to account for the contribution of the i-th
dataset to the total covariance. Mathematically the prob-
lem can be described as finding the optimal parameters
so that the covariance between input and response (sum-
marized in Z and U) is optimized. The results improve
substantially by introducing a constraint or a penaliza-
tion to the objective function that needs to be optimized:
sMBPLS uses a Lasso penalization - many different penal-
ization choices are possible (for details see e.g. [25]). The
effect of this penalization is often called sparsity, meaning
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that negligible coefficients tend to be drawn to zero. So
the final function to be maximized can be expressed as
(Z,U,wi, v,b) = cov(Z,U) −
3∑
i=1
Pλi(wi) − Pλ4(v) (1)
with the further restrictions that vectorswi, v,bmust have
norm equal to 1; here Pλi are the Lasso penalizations. In
order to estimate the optimal parameters in (1) Li et al.
develop an ad hoc algorithm [4].
Gene-wise weights
Multi-omics gene-wise weights have been proposed to
fuse three types of omics into a unique summary score
for each gene [19]. These scores si are defined using gene




) · i, (2)
where wmei and wcni are measures of the expression differ-
ence of the i-th gene between samples with high and low
values of DNAmethylationwmei and CNVwcni , while i is a
normalization term.More precisely, layer-specific weights
for each gene are calculated using the mean and standard
deviation of gene expression
wi = mi,1 − mi,0
σi,1 + σi,0 , (3)
where the suffixes 1 and 0 indicate, respectively, sam-
ples having high and low values of the other omics (DNA
methylation or CNV). In summary, each variable is asso-
ciated with the sum of a set of signal-to-noise scores, each
of which is calculated considering the means and standard
deviations of the variable using two subsets of samples of a
given dataset (e.g. gene expression) defined on the basis of
the values of the same variable in another layer (e.g. CNV
or methylation).
Network-free bayesian (NF-BY)
Parametric or “strict” bayesian frameworks assume that
the prior probability distribution follows a specific model
dependent on one or more parameters. If the prior fits
the data well parametric bayesian methods usually out-
perform non-parametric ones. On the other hand, if the
initial guess for the prior is hard or even impossible to
formalize, non-parametric or distribution-free methods
are preferred [7]. It is important to remark that non-
parametric or distribution-freemethods are characterized
by the fact that - unlike their parametric counterpart - the
priors are not identifiable with a given family of probabil-
ity distributions depending on one or more parameters,
since this family would be too large, therefore introduc-
ing the need of an alternative definition of the priors in
which - roughly speaking - the parameters themselves are
supposed to be random. In this context, Antoniak [26]
defined Mixtures of Dirichelet Processes (DPM) a use-
ful set of priors for many non-parametric problems, that
was taken as a starting point for many recent works aim-
ing at the integration of multi-omics, such as TMD [27],
MDI [28], PSFD [29], while, for example, iCluster [12]
is a parametric method. The choice between parametric
and non-parametric models is often not arbitrary, but it is
driven by the type of data to be modeled.
iCluster [12] and MDI [28] have been developed with
the main objective of sample clustering and can be applied
to different types of omics. iCluster [12] takes as input
two or more matrices and finds multi-omics clusters
jointly estimating, by means of a prior-posterior bayesian
structure, the clusteringZ, which is modeled as a Gaussian
latent variable having layer-specific weights and parame-
ters. MDI (multiple dataset integration) [28] carries out
the same objective (clustering) using a bayesian approach
to jointly estimate the parameters of Dirichelet Process
Mixture models. These models are applied to find clusters
and relevant genes (features).
An approach closely related to MDI is Savage’s Tran-
scriptional Modules Discovery (TMD) [27] who also
adopts a mixture modeling approach, using hierarchi-
cal Dirichelet process to perform integrative modeling
of two datasets. Conversely to MDI, TMD aims at the
identification of molecular mechanisms.
Patient-Specific Data Fusion (PSDF) [29] extends the
TMD model for assessing the concordance of biological
signals of samples in the two datasets taken into account
(CNV and gene expression data). PSDF can be used to
shed light on molecular mechanisms and cluster samples.
Coalesce [30] is a combinatorial algorithm specifically
developed for the identification of regulatory modules
from the analysis of gene expression and DNA sequence
data. The multi-omics probability for a gene to be
included into a module is calculated combining omics
specific probabilities through the Bayes’ rule.
Since iCluster was introduced, it is often being cited
by subsequent works as an innovative reference approach
for multi-omics clustering of samples, while, as already
said, MDI shares a multi-layer analysis approach (based
on Dirichelet Process Mixture models) with other recent
methods. Hence, we will focus on iCluster andMDI in the
following.
Bayesian latent variablemodels
In 2009, Shen et al. developed a joint variable model
for integrative clustering, naming the resulting method-
ology iCluster [12]. Considering N datasets referred to
the same group of samples, iCluster formulates sample
clustering as a joint latent variable that needs to be simul-
taneously estimated from multiple genomic data types.
The first step is to capture the similarities among genomic
information in each data set, so that the within-cluster
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variance is minimized. This task is performed by an opti-
mization through PCA of the classicalK-means clustering
algorithm, with the additional advantage of reducing the
dimensionality of the data: if k is the number of clus-
ters, the dimensionality n of the genomic data is basi-
cally reduced to the first k-1 principal directions. Second,
the clustering scheme in each layer is represented as a
Gaussian latent variable model with the Gaussian latent
component Z capturing the dependencies across the data
types. Dealing with N different omics measurements on
the same p samples X1,X2, . . . ,XN , each one of dimension
p × ni with usually p << ni, the model can be written in
the following fashion:
Xi = Wi · Z + i (4)
where the matrices Wi are the p × k − 1 weight matri-
ces and i are the independent error terms. After taking a
continuous parametrization Z∗ of Z and assuming Z∗ ∼
N(0, I) and  = (1, . . . , N ) ∼ N(0, cov()), likelihood-
based inference is obtained through the Expectation-
Maximization (EM) algorithm [31]. iCluster requires the
number of desired clusters k as input for the algorithm.
Recently, Kirk et al. [28] presented a bayesian method
for the unsupervised integrative modeling of multiple
datasets. MDI integrates information from a wide range
of different datasets and data types simultaneously. In
a general N-components mixture model, the probability
density for the data p(X) is modeled using Dirichelet-




wk · π(X|θk) (5)
where wk are the mixture proportions, θk are the param-
eters associated to the k-th component and π is a para-
metric density. Component allocation variables and some
additional parameters - conversely from the TMD model
[27] - are introduced in order to capture the dependencies
among these models and find clusters of genomic enti-
ties having the same behavior in different datasets. The
modeling structure of the multi-layer dataset exploits the
mathematical connection between mixture models and
Dirichelet Processes, a non-trivial problem: for details see
[32]. In this way is possible to construct a prior proba-
bility for each dataset where the probability distribution
is parametrized by component allocation variables. Infer-
ence on such parameters is performed through Gibbs
sampling. Finally, in order to identify groups that tend to
cluster together in multiple datasets, it is natural to exploit
the posterior probability as a metric in order to decide
whether or not a connection among each couple of genes
is strong enough across the dataset.
Both MDI and iCluster carry out simultaneous inte-
grative clustering of multiple omics datasets. However, in
contrast to MDI, iCluster seeks to find a single common
clustering structure for all datasets.
Network-based non-bayesian (NB-NBY)
Methods that we have assigned to this category make
either use of molecular interaction data or use networks
defined from correlation analysis.
SteinerNet [33], the method proposed by Mosca et al.
[16], stSVM [34] and nuChart [35] share a common strat-
egy: the analysis of a multi-weighted graph that carry
multi-omics information. SteinerNet [33] is a method that
identifies molecular sub-networks using omics datasets
and a given molecular network. In order to recon-
struct response pathways, SteinerNet finds a solution
to the prize-collecting Steiner tree (PCST) problem, a
minimum-weighted subtree that find an optimal net-
work subject to weights assigned to vertexes and edges
on the basis of input datasets. Similarly, multi-objective
optimization (MOO) has been recently proposed for the
extraction of sub-networks enriched in multi-omics infor-
mation [16]. Sub-networks are extracted on the basis of
multiple criteria applied to a network that encodes sev-
eral layers of biological information as vertex and edge
weights. Also stSVM (smoothed t-statistic support vec-
tor machine) method [34] loads gene-wise statistics from
multiple omics (miRNA and mRNA) on a molecular net-
work known a priori. Then, a network diffusion method is
used to smooth the statistics according to network topol-
ogy. Significant genes are then used to train a classifier
(a SVM) that predicts the type of sample (e.g. early ver-
sus late disease relapse). NuChart [35] is a method for the
annotation and statistical analysis of a list of genes with
information relying on Hi-C data (genome-wide data of
chromosomal interactions [36]). NuChart identifies Hi-C
fragments by means of DNA sequencing data and cre-
ates gene-centric neighborhood graphs on which other
omics data (e.g. gene expression) are mapped and jointly
analyzed.
ENDEAVOUR [37] calculates gene-wise statistics from
heterogeneous genome-wide data sources (including
molecular interactions) and ranks genes according to their
similarity to known genes involved in the biological pro-
cess under analysis. Single layer prioritizations are then
integrated into a global ranking by means of order statis-
tics. In 2007 De Bie et al. [18] proposed a kernel-based
data fusionmethod for gene prioritization, which operates
in the same setting of ENDEAVOUR. Kernels represent-
ing gene information in each layer are linearly combined
in order to fuse the information and identify disease genes.
SNF (Similarity Network Fusion) [17] is a method that
computes and fuses patient similarity networks obtained
from each omics separately, in order to find disease
subtypes and predict phenotypes. Conversely from the
other methods of this section, SNF uses sample-sample
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networks obtained from correlation analysis. The key step
of SNF is to iteratively and simultaneously update the
global patient similarity matrix of each layer using a local
K-nearest neighbours (KNN) approach combined with
the global similarity matrices of the other layers. Fusion is
then completed by averaging the similarity matrices once
the iterative upgrading is performed.
Recently, a type of multi-partite network (multiplex)
has been introduced as a novel theoretical framework
for network-based multi-layer integrative analysis [38].
Multiplex networks are multi-layer systems of vertexes
that can be linked in multiple interacting and co-evolving
layers. This approach has been proposed for the analysis of
gene expression data in brain [39] and cancer [40]. In the
second example, a sample-sample duplex (two-layers net-
work) has been generated based on correlation between
gene expression profiles, revealing structural similarities
and differences between two classes of samples. Thanks to
their general formalism, in principle multiplex networks
can be applied to the joint analysis of several types of
omics (e.g. one type of omics for each layer), also for
multi-level clustering purposes [41].
In the following subsections, we will discuss in more
detail network diffusion, fusion of similarity networks
and heterogeneous/multiplex networks. Methods that
simulate the diffusion of information throughout a net-
work are being increasingly used, since they allow to
study how the information (e.g. differential expression,
sequence variations) initially available in one or more
network components (vertexes) affects other network
regions [42]. SNF [17] is a diffusion-based strategy that
can be easily extended to the analysis of a wide range of
multi-omics data. Heterogeneous and multiplex networks
are promising frameworks for innovative multi-omics
data analysis.
Diffusion processes on networks
Network diffusion algorithms define a vector of scores σ
associated with network vertexes on the basis of initial
conditions x0 and network topology τ , usually represented
by the adjacency matrix A or the Laplacian matrix L of the
graph.
An application of such techniques is found in stSVM
[34], where a p-step randomwalk kernelK is used in order
to smooth the t-statistics x0, which assess the differential
expression of genes. The kernel is defined as
K = (α · I − L′)p (6)
where α is a constant, L′ is the symmetrically normal-
ized Laplacian matrix of the graph and p is the number of
random walk steps. The smoothing of the t-statistic x is
simply computed using the kernel K :
x = xT0 · K (7)
In this case the influence of a node on the network is
controlled by the parameter p. Basically, the information
initially available in each vertex is distributed to its neigh-
bors by means of the application of K. For a deeper insight
of diffusion kernels see [43].
In other diffusion models, the network-based scores
σ = σ(X0, τ) are the steady state solution of a dis-
crete or continuous diffusion process on the network that
can have either a deterministic or a stochastic interpre-
tation. An example of such a technique is the network
propagation algorithm exploited in the work of Hofree
et al. [44]: after mapping a patient mutation profile onto
a molecular network, network propagation is used to
“smooth” the mutation signal across the network. Net-
work propagation uses a process that simulates a ran-
dom walk on a network with restarts according to the
function:
x(t) = αA′ · x(t) + (1 − α)x0, (8)
where x0 is a vector representing some kind of genomic
information about a patient (in this case mutation sig-
nal), A′ is the symmetrically normalized adjacency matrix
capturing correlations among genes, and α ∈ (0, 1) con-
trols how much information is retained in the nodes with
respect to how much is not. For t → ∞ for each patient,
the discrete array x0 is smoothed into a real-valued array
σ = x(∞).
Network diffusion processes are often based on an
actual physical model, having the benefit of exploiting
physical quantities and concepts to drive the setting of
the parameters. For example Vandin and Upfal [45] pre-
sented a computationally efficient strategy for the iden-
tification of sub-networks considering the hydrodynamic
model introduced by Qi et al. [46]: fluid is pumped into
the source node s at a constant rate, diffuses through
the graph along the edges, and is lost from each node
at a constant first-order rate until a steady-flow solution
is reached.
The presence of random walks on a graph allows con-
nections to many other physical models. For example,
another interesting framework is represented by electric
circuits [47], where the relation between the random walk
of electrons on a circuit and Kirkhoff laws is exploited.
eQed is a recent application of the latter [48]. Recently
Mirzaev and Gunawardena have collected and rigorously
demonstrated some of the most important mathematical
results in the context of information dynamics in a linear
framework, also suggesting a possible stochastic interpre-
tation of such diffusion processes on the network in the
Chemical Master Equation formalism [49].
Fusion of similarity networks
An interesting strategy to perform simultaneous network-
based integration of omics is the one at the basis of SNF
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[17]. A number N of different patient similarity networks
with associated global similarity matrices Pi,0 are defined
from N datasets. Let’s assume N = 2 for the sake of clar-
ity. Then, for each layer a KNN local similarity matrix Si
is introduced in order to retain only robust information.
Subsequently, global similarity matrices are smoothed by
two parallel interchanging diffusion processes that con-
sist of the upgrading of the global similarity matrices with
respect to the local similarity matrices of the other layer:
P1(t + 1) = S1 · P2(t) · ST1
P2(t + 1) = S2 · P1(t) · ST2 (9)
having initial condition Pi(0) = Pi,0. After convergence,
the fused similarity matrix is then defined as the aver-
age of P1 and P2 . The result is a similarity matrix that
can be viewed as the weighted adjacency matrix of a net-
work built by fusing the similarity networks associated
with each layer [17].
Heterogeneous networks andmultiplex
In the context of multi-omics data analyses, multiple (k)
layers can be represented by means of k networks. In this
context, we can distinguish between two kinds of formal-
ism: heterogeneous networks and multiplex networks.
Heterogeneous networks consider k different kinds of
nodes, each type corresponding to a different layer of
biological information. In this framework, intra-layer con-
nections and inter-layer connections are formally treated
in the same way, even if they can be weighed differ-
ently. The multi-layered information is therefore some-
how squeezed on just one dimension and the properties
of the resulting graph can be used to manipulate the data.
For example, for k = 2 we can have vertexes of genes layer
g1, g2, . . . , gn and proteins layer p1, p2, . . . , pm. The Lapla-
cian matrix of this heterogeneous network is a (n + m) ×







where Lg and Lp are the Laplacian matrices of respectively
gene and protein layers, while the matrices Bgp and Bpg
contain the information about inter-layer connections; in
the case the graph is undirected Bpg = BTgp. An example of
application of heterogeneous network for modeling gene-
phenotype networks was presented by Li and Patra [50].
Multiplex networks [38] are instead multi-partite net-
works in which each of the k layers models a different
information about the same set of vertexes v1, v2, . . . , vn.
For example, let us consider two omics, represented as a
two-layered multiplex composed of two sample × sample
networks, where the edges of each network are placed in
function of the sample-sample correlations found in the
associated omics. Then, it is possible to analyze inter-layer
correlations by means of multilnks, a quantity that sum-
marizes the connectivity of each pair of samples across
the layers. More precisely, a multilink is a k-dimensional
binary array whose i-th component is set to 1 if the two
samples are connected in the i-th layer and 0 otherwise.
The formalism of multilink is the basis to define weighted
measures and overlaps of the multiplex networks and
other physical quantities, such as entropy, which intro-
duces a theoretical framework to quantify and detect the
information stored in complex networks [38, 40].
Network-based bayesian (NB-BY)
In this section we deal with methods that can be classi-
fied as both network-based and bayesian; these features
select mainly those methods that are somehow related
to bayesian networks (BNs). BNs are probabilistic mod-
els composed of a graph and a local probability model
that can be either parametric or not. BNs represent an
important area of machine learning theory and many
applications of this topic are found in diverse fields. BNs
can be thought as a combination of network theory and
probability theory.
Within the BN framework an important method for
multi-omics data integration is Paradigm [51]. Its goal
is the definition of patient-specific pathway activities by
means of probabilistic inference. Each biological entity
(gene, protein, etc.) is modeled as a factor graph that can
be defined to host a wide range of multi-omics informa-
tion, and is associated with a prior probability of being
activated in a given pathway.
Conexic, a bayesian network-based algorithm, has been
introduced for the identification of driver mutations in
cancer through the integration of gene expression and
CNVs [11]. Conexic is based on a bayesian scoring func-
tion that evaluates how each candidate gene, or a combi-
nation of genes, predicts the behavior of a gene expression
module across tumor samples. Networks, more precisely
regression trees, are used to encode regulation programs.
Below, we will focus on the theoretical setup of the BN
developed by Paradigm [51].
Paradigm: an application of bayesian networks
The goal of Paradigm is the definition of an entities
× samples matrix called IPA (inferred pathway activity)
where IPAij reports a score that accounts for how likely the
biological entity i is activated/null/deactivated in sample j.
The model is network-based since correlations between
data points aremodeled as factor graphs
 = (φ1, . . . ,φm)
that are used for assigning a probability for the genomic
entities or variables X = (X1, . . . ,Xn):
P
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where Z is a normalization constant accounting for all of
the possible settings of the variables X and Xj is a set con-
stituted by xj and its “parents” Pa(xj) that are the nodes
that have a link directed to xj in the network. It is impor-
tant to underline that the number of features m is much
less than 2n − 1 (the number of possible edges in the
graph): this “sparsity” facilitates integration. In this way it
is possible to assign to each gene’s xi activity a first a prior
probability distribution and then probability distribution
consistent with the dataset measurements D:
P







 is the fully specified factor graph, S ⊂Ai(a)∪D Xj
are all the possible configurations consistent with both the
dataset measurements D and the fact that gene i is acti-
vated (Ai(a) is the the singleton assignment set {xi = a});
the proportionality constant is the same as Eq. (11). The
junction free inference algorithm and the belief propaga-
tion algorithm are used to infer the probabilities while EM
algorithm [31] is used to learn the parameters. After infer-
ence log odds of the posterior probability distribution are
used to measure the activity of each gene.
Conclusions
Methods for the analysis of multiple layers of biological
information pave the way for a more comprehensive and
deeper understanding of biological systems. Indeed, sev-
eral authors were able to show that the integration of
multi-dimensional datasets leads to better results from
a statistical and a biological point of view than single
layer analyses. For example, using MCD, Charj et al. [13]
showed that the integration of DNA copy number, LOH,
DNA methylation and gene expression data permits the
identification of a higher number of DNA explained gene
expression changes and a set of genes that would have
been missed in standard single layer analysis; Liu et al.
[21] reported an improvement in the identification of
pathways and networks integrating miRNA, mRNA and
proteins; Wang et al. [17] showed that their network
fusion approach applied to gene expression and DNA
methylation lead to clusters of patients (corresponding to
cancer subtypes) with significantly different survival rates.
A better understanding of the algorithms underlying
integrative approaches is important for their correct
application and further development. Network-based
approaches use graphs for modeling and analyzing rela-
tionships among variables and are one of the most impor-
tant classes of multi-omics methods. These approaches
take advantage of algorithms for graph analysis. In par-
ticular, algorithms that propagate information on net-
works are being proposed in several applications and
are often related to actual physical models. Networks
allow to model the intricate cell’s wiring diagram and
to use it as a framework for the integrated analysis of
layers of biological information. However the incom-
pleteness of experimentally detected molecular interac-
tions is still a significant limit. Further, better tools of
analysis are required, because assumptions like normal-
ity and variable independence are often not fulfilled [5].
Multi-layer network-based frameworks, such as hetero-
geneous and multiplex networks, allow the definition
of novel tools for the integration of omics. For exam-
ple, the already mentioned methods of network diffusion
can be extended to such frameworks in order to get
multi-omics propagation scores, and new clustering algo-
rithms could be developed based on these multi-layer
relationships. Moreover, multiple omics data can be nat-
urally embedded in a heterogeneous network framework,
for example metabolomics and genomics data, consid-
ering genes that codify for enzymes as inter-layer links,
and intra-layer relationship given by a priori biological
knowledge (like protein-protein interaction network) or
by network reconstruction based on metabolomics and
transcriptomics data.
Another class of interesting approaches relies on Bayes’
rule. Multilevel bayesian models (parametric or not) are
facing the multi-omics challenge by building frameworks
that facilitate a biologically appropriate formalism for the
assumptions on the prior distribution (e.g. factor graphs,
mixturemodels) and by programming non-trivial and effi-
cient algorithms for parameter estimation. Assuming the
bayesian framework is an interesting choice because it
reduces the integration to the estimate of a smaller set of
parameters, simultaneously suggesting a clear integration
scheme. A limitation of such models is that for paramet-
ric methods the output strongly depends on how well
the prior distribution assumption is able to capture the
core information of the given dataset. Distribution-free
approaches do not have such a problem but sometimes
tend to lack in accuracy. In the network-based context the
application of bayesian networks represents an interesting
compromise between networks and probability theory.
The bayesian framework is promising also regarding the
issue of noise, because errors have the possibility to be
formally taken into account from the beginning of the
analysis.
Not surprisingly, genomics and transcriptomics are
the two omics for which many and more established
approaches of multi-layer analysis exist. However, the
availability of methods that are not tailored for specific
types of omics extends the applicability of integrative
approaches also to omics that are still less covered by
specific methods, such as proteomics, metabolomics or
glycomics.
One of the main limitations of integrative approaches
is related to dimensionality. In fact, if on one hand more
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layers correspond to a more complete picture of the bio-
logical system, on the other hand the dimensionality of
the problem increases. However, a priori information on
the relationships among the components of the biological
system should help in reducing false discoveries.
Several methods are implemented using R [52], con-
firming the prominent role of this programming language
in the analysis of biological data, and Matlab [53]. The
availability of well-documented and user-friendly imple-
mentations is a crucial factor for the usability and spread
of interesting methods. However, there are still several
cases in which software packages are not provided.
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